Bouchard; Annie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bouchard; Annie.The latest application filed is for "novel lipids".

Company Profile

10.6.14

Bouchard; Annie - Stoke CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Lipids App 20220056057 - McChesney; James ; et al.	2022-02-24
Novel Lipids App 20210198294 - McChesney; James ; et al.	2021-07-01
Cardiopathy-reducing phosphodiester lipids Grant 10,975,111 - McChesney , et al. April 13, 2	2021-04-13
Liposomal Mitigation of Drug-Induced Inhibition of the Cardiac IKR Channel App 20200108056 - Helson; Lawrence ; et al.	2020-04-09
Liposomal mitigation of drug-induced inhibition of the cardiac I.sub.Kr channel Grant 10,532,045 - Helson , et al. Ja	2020-01-14
Protective Effect Of Dmpc, Dmpg, Dmpc/dmpg, Lysopg And Lysopc Against Drugs That Cause Channelopathies App 20190388422 - Helson; Lawrence ; et al.	2019-12-26
Novel Lipids App 20190389888 - McChesney; James ; et al.	2019-12-26
Liposomal Mitigation Of Drug-induced Inhibition Of The Cardiac Ikr Channel App 20190320975 - Helson; Lawrence ; et al.	2019-10-24
Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies Grant 10,449,193 - Helson , et al. Oc	2019-10-22
Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel Grant 10,349,884 - Helson , et al. July 16, 2	2019-07-16
Protective Effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC Against Drugs that Cause Channelopathies App 20190167585 - Helson; Lawrence ; et al.	2019-06-06
Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies Grant 10,258,691 - Helson , et al.	2019-04-16
Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies Grant 10,238,602 - Helson , et al.	2019-03-26
Compositions And Method For Reducing Cardiotoxicity App 20190008878 - Bouchard; Annie	2019-01-10
Protective Effect Of Dmpc, Dmpg, Dmpc/dmpg, Lysopg And Lysopc Against Drugs That Cause Channelopathies App 20180055770 - Helson; Lawrence ; et al.	2018-03-01
Prevention Of Drug-induced Atrio-ventricular Block App 20170312366 - Lawrence; Helson ; et al.	2017-11-02
Liposomal Mitigation Of Drug-induced Inhibition Of The Cardiac Ikr Channel App 20170119802 - Helson; Lawrence ; et al.	2017-05-04
Protective Effect Of Dmpc, Dmpg, Dmpc/dmpg, Lysopg And Lysopc Against Drugs That Cause Channelopathies App 20170035887 - Helson; Lawrence ; et al.	2017-02-09
Protective Effect Of Dmpc, Dmpg, Dmpc/dmpg, Egpg, Lysopg And Lysopc Against Drugs That Cause Channelopathies App 20150343063 - Helson; Lawrence ; et al.	2015-12-03
Liposomal Mitigation Of Drug-induced Inhibition Of The Cardiac Ikr Channel App 20150164878 - Helson; Lawrence ; et al.	2015-06-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.